Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.
about
Suppression of APOBEC3-mediated restriction of HIV-1 by VifAPOBEC3 Interference during Replication of Viral GenomesMulti-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapyQuantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restrictionSmall-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.Atomic force microscopy studies provide direct evidence for dimerization of the HIV restriction factor APOBEC3GIntensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain.Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif.Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif proteinHost restriction factors in retroviral infection: promises in virus-host interaction.Host restriction of lentiviruses and viral countermeasures: APOBEC3 and Vif.The role of cytidine deaminases on innate immune responses against human viral infections.Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 VifMaking Sense of Multifunctional Proteins: Human Immunodeficiency Virus Type 1 Accessory and Regulatory Proteins and Connections to Transcription.
P2860
Q27025150-A4949336-862A-4E17-A331-E45C9AA11A74Q28081195-5079D32E-507F-4B7B-B61B-66E6ADB2C911Q28480578-4D4EE3D8-8454-49FF-8B78-C623C83518C9Q34020228-8C980E26-C691-4901-9BC9-156F74510DF4Q34179686-C1C4003A-3362-42F1-8C1E-7C1C363D1946Q34536866-D54301C7-209D-4842-B001-3EA1F9914E1AQ34719668-96A35E54-98EA-44A8-987A-098AD3DFFF96Q35113622-B9214684-AC1B-4E23-B46F-76A091487436Q36432758-403F2EB0-C78E-4B81-87CE-CEAE66E77632Q36548179-15ACFC7B-F274-4F07-B3D6-66B4D79A8162Q38125575-E824ED59-2024-4E5A-A765-D6B0C286A6D6Q41812539-C71CB0AD-245D-402A-8000-4D2CA20021D3Q41897467-486529E2-E3D1-411B-AA97-DC543749ABAAQ41927990-1D1EE384-3BB3-47A0-9E56-9AAAF74FD9FE
P2860
Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.
@ast
Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.
@en
type
label
Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.
@ast
Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.
@en
prefLabel
Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.
@ast
Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.
@en
P2860
P356
P1433
P1476
Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.
@en
P2093
Judd F Hultquist
P2860
P356
10.2217/FVL.09.59
P577
2009-11-01T00:00:00Z